Publicacións en colaboración con investigadores/as de Hospital Universitario San Cecilio (19)

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

2020

  1. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

  2. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224

2017

  1. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430

2016

  1. Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)

    Medicine (United States), Vol. 95, Núm. 9

  2. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

2011

  1. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 1 SUPPL. 64

2010

  1. Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis

    Arthritis Research and Therapy, Vol. 12, Núm. 2

  2. Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2076-2080

  3. Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 11, pp. 2331-2333

  4. Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1 SUPPL. 57

  5. Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 1, pp. 136-140

  6. Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 1, pp. 131-135

  7. Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1 SUPPL. 57

  8. Lack of association between the rs6920220 (G/A) polymorphism of the 6q23 region and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 5, pp. 1020-1023

  9. Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1502-1504

  10. Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis

    Human Immunology, Vol. 71, Núm. 5, pp. 525-529

2009

  1. Association between Toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 36, Núm. 7, pp. 1501-1506

  2. Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 36, Núm. 5, pp. 1021-1025